Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparative study of fragment screening methods on the p38α kinase: new methods, new insights.
Pollack SJ, Beyer KS, Lock C, Müller I, Sheppard D, Lipkin M, Hardick D, Blurton P, Leonard PM, Hubbard PA, Todd D, Richardson CM, Ahrens T, Baader M, Hafenbradl DO, Hilyard K, Bürli RW. Pollack SJ, et al. Among authors: hafenbradl do. J Comput Aided Mol Des. 2011 Jul;25(7):677-87. doi: 10.1007/s10822-011-9454-9. Epub 2011 Jul 6. J Comput Aided Mol Des. 2011. PMID: 21732248 Free PMC article.
Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology.
Kéri G, Székelyhidi Z, Bánhegyi P, Varga Z, Hegymegi-Barakonyi B, Szántai-Kis C, Hafenbradl D, Klebl B, Muller G, Ullrich A, Erös D, Horváth Z, Greff Z, Marosfalvi J, Pató J, Szabadkai I, Szilágyi I, Szegedi Z, Varga I, Wáczek F, Orfi L. Kéri G, et al. Assay Drug Dev Technol. 2005 Oct;3(5):543-51. doi: 10.1089/adt.2005.3.543. Assay Drug Dev Technol. 2005. PMID: 16305311 Review.
Signalling inhibitors against Mycobacterium tuberculosis--early days of a new therapeutic concept in tuberculosis.
Hegymegi-Barakonyi B, Székely R, Varga Z, Kiss R, Borbély G, Németh G, Bánhegyi P, Pató J, Greff Z, Horváth Z, Mészáros G, Marosfalvi J, Erōs D, Szántai-Kis C, Breza N, Garavaglia S, Perozzi S, Rizzi M, Hafenbradl D, Ko M, Av-Gay Y, Klebl BM, Orfi L, Kéri G. Hegymegi-Barakonyi B, et al. Curr Med Chem. 2008;15(26):2760-70. doi: 10.2174/092986708786242886. Curr Med Chem. 2008. PMID: 18991635
Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives.
Székelyhidi Z, Pató J, Wáczek F, Bánhegyi P, Hegymegi-Barakonyi B, Erös D, Mészáros G, Hollósy F, Hafenbradl D, Obert S, Klebl B, Kéri G, Orfi L. Székelyhidi Z, et al. Bioorg Med Chem Lett. 2005 Jul 1;15(13):3241-6. doi: 10.1016/j.bmcl.2005.04.064. Bioorg Med Chem Lett. 2005. PMID: 15925511